Results 251 to 260 of about 97,810 (274)

Clinical remission rate and drug withdrawal status in articular juvenile idiopathic arthritis. [PDF]

open access: yesPediatr Rheumatol Online J
Oshima A   +4 more
europepmc   +1 more source

Association Between Biologics and Janus Kinase Inhibitors With Inflammatory Bowel Disease as Paradoxical Reactions: A Real‐World Assessment

open access: yesUnited European Gastroenterology Journal, EarlyView.
ABSTRACT Background and Objective With limited evidence connecting paradoxical inflammatory bowel disease (paradoxical IBD) to the newest biologics and Janus kinase inhibitors, our study aims to investigate the occurrence of paradoxical IBD induced by these agents in treating other immune‐mediated inflammatory diseases (IMIDs).
Zhi‐Qing Zhan   +3 more
wiley   +1 more source

Combination of clinical factors predicts successful glucocorticoid withdrawal in systemic lupus erythematosus (SLE): results from a multicentre, retrospective cohort study. [PDF]

open access: yesRMD Open
Katechis S   +14 more
europepmc   +1 more source

The Role of Environmental Factors Prior to Diagnosis on the Activity and Severity of Inflammatory Bowel Diseases—Results From the Prospective Population‐Based Copenhagen Inflammatory Bowel Disease Inception Cohort

open access: yesUnited European Gastroenterology Journal, EarlyView.
ABSTRACT Background The influence of environmental factors on the severity of early inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), is unclear. Herein, we aimed to investigate the role of environmental factors in the initial phenotype, activity, and severity of IBD.
Mohamed Attauabi   +4 more
wiley   +1 more source

Long‐Term Impact of COVID‐19 on Disorders of Gut–Brain Interaction: Incidence, Symptom Burden, and Psychological Comorbidities

open access: yesUnited European Gastroenterology Journal, EarlyView.
ABSTRACT Background The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic has highlighted the potential exacerbation of gastrointestinal symptoms in patients with disorders of gut‐brain interaction (DGBIs). However, the distinct symptom trajectories and psychological burden in patients with post‐COVID‐19 DGBIs compared with patients
Giovanni Marasco   +68 more
wiley   +1 more source

Firsekibart in acute gouty arthritis. [PDF]

open access: yesJ Transl Med
Xue Y   +12 more
europepmc   +1 more source

Faecalibacterium Diversity in the Gut Microbiome of Crohn's Disease Patients

open access: yesUnited European Gastroenterology Journal, EarlyView.
ABSTRACT Faecalibacterium has recently garnered attention for its potential health implications. To better understand its role, we developed and assessed real‐time PCR assays for detecting and quantifying various Faecalibacterium species in human stool samples from both healthy individuals and Crohn's disease patients, either in flare or remission. The
Paul Mclellan   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy